Aaron Balog Selected Research

BMS 641988

8/2015	Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.
8/2009	Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aaron Balog Research Topics

Disease

8	Neoplasms (Cancer) 09/2022 - 08/2009
5	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 08/2009
2	Melanoma (Melanoma, Malignant) 07/2021 - 03/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 07/2021 - 03/2021
1	Leukemia 05/2015

Drug/Important Bio-Agent (IBA)

4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 09/2022 - 01/2021
3	linrodostatIBA 09/2022 - 01/2021
2	Heme (Haem)IBA 02/2021 - 01/2021
2	bicalutamide (Casodex)FDA LinkGeneric 08/2015 - 08/2009
2	BMS 641988IBA 08/2015 - 08/2009
2	Androgen Receptors (Androgen Receptor)IBA 04/2011 - 08/2009
1	DioxygenasesIBA 02/2021
1	EnzymesIBA 02/2021
1	Mesylates (Mesylate)IBA 01/2021
1	KynurenineIBA 01/2021
1	LyasesIBA 01/2016
1	benzimidazoleIBA 01/2016
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2016
1	compound 18IBA 01/2016
1	Androgen Receptor AntagonistsIBA 08/2015
1	BMS-871IBA 05/2015
1	compound 30IBA 05/2015
1	IgG Receptors (Fc gamma RI)IBA 12/2014
1	AntigensIBA 12/2014
1	Hormones (Hormone)IBA 08/2009
1	Androgen Antagonists (Antiandrogens)IBA 08/2009

Therapy/Procedure

4	Immunotherapy 07/2021 - 01/2021
1	Castration 01/2016
1	Biological Therapy 12/2014